Anil Chandraker, MBChB
Enriched profileProfessor of Medicine and Chief, Division of Renal Medicine, UMass Chan Medical School · UMass Chan Medical School
Anil Chandraker is Professor of Medicine and Chief, Division of Renal Medicine, UMass Chan Medical School at UMass Chan Medical School. OpenAlex indexes 315 publications with 13,041 citations (h-index 60); ClinicalTrials.gov lists 9 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Nephrology profiles in the findmyKOL directory.
Data verified 17 Aug 2026
Overview
Updated 27 Aug 2026
Anil Chandraker, MBCHB, is Professor of Medicine and Chief, Division of Renal Medicine, UMass Chan Medical School. The public record shows 315 publications with 13,041 citations (h-index 60), centered on Renal Transplantation Outcomes and Treatments, T-cell and B-cell Immunology, Transplantation: Methods and Outcomes. It also documents an investigator role on 9 registered clinical trials, industry payments reported by 15 companies, 4 NIH-funded awards (2001–2013).
- Most recent indexed publication: 2024 · Journal of the American Society of Nephrology
- Top research focus: Renal Transplantation Outcomes and Treatments
- 9 registered trials on ClinicalTrials.gov
- Open Payments reporting from 15 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 7 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 159.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 9 registered studies on ClinicalTrials.gov. The most recent:
- Lipid Management in Renal Transplant Recipients Using Evolocumab.
Sponsor: Brigham and Women's Hospital
- Retrospective Multicenter Study to Determine 4-Year Clinical Outcomes in Subjects Previously Enrolled in the CTOT-05 Study
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
- Efficacy and Safety of Eculizumab for Treatment of Antibody-mediated Rejection Following Renal Transplantation
Sponsor: Brigham and Women's Hospital
Industry payments
Updated 27 Aug 2026
15 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- VERTEX PHARMACEUTICALS INCORPORATEDProgram year202511 payments$20,150openpaymentsdata.cms.gov ↗
- Alexion Pharmaceuticals, Inc.Program year20259 payments$18,124openpaymentsdata.cms.gov ↗
- SANOFI-AVENTIS U.S. LLCProgram year20251 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
37%Beta blocker14.8%Metoprolol Succinate100%Part D<11 patientsACE inhibitor11.9%Lisinopril100%Part D<11 patientsMetabolism & gastrointestinal
32.6%Corticosteroid24.4%Prednisone100%Part D≥13 patientsProton pump inhibitor8.1%Omeprazole100%Part D<11 patientsGenitourinary & hormones
11.1%alpha-Adrenergic Blocker11.1%Tamsulosin Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
4 NIH research awards on record, funded 2001–2013 per NIH RePORTER. The latest:
- Novel Therapies to Improve Renal and Cardiac Allograft Outcomes
Brigham and Women'S Hospital
FY2013$2,543,579U01AI063623 - Clinical characterization of the APOL1-associated phenotype
Beth Israel Deaconess Medical Center
FY2011$492,908R24DK092158
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Posoleucel in Kidney Transplant Recipients with BK Viremia: Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial.
Journal of the American Society of Nephrology
Clinical Trial2024 - Comparative Effectiveness of PET and SPECT MPI for Predicting Cardiovascular Events After Kidney Transplant.
Circulation. Cardiovascular imaging
Article2024 - Human leukocyte antigen antibody sensitization, lung transplantation, and health equity.
American journal of transplantation
Article2022 - Full facial retransplantation in a female patient-Technical, immunologic, and clinical considerations.
American journal of transplantation
Case Report2021 - Follicular T cells mediate donor-specific antibody and rejection after solid organ transplantation.
American journal of transplantation
Article2021
Most-cited works
by citation count (OpenAlex)- 01Endothelial-to-mesenchymal transition contributes to cardiac fibrosisArticle2,218 citations2007
- 02The promise of organ and tissue preservation to transform medicineArticle542 citations2017
- 03Role of the PD-1 Pathway in the Immune ResponseArticle440 citations2012
- 04EFFECTS OF EXPLOSIVE BRAIN DEATH ON CYTOKINE ACTIVATION OF PERIPHERAL ORGANS IN THE RAT1Article405 citations1998
- 05
Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/anil-chandraker-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - ResearchGate
researchgate.net/profile/Anil-Chandraker
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗ - Facebook
facebook.com/anil.chandraker.16
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →facebook.com ↗
Mentions by others
where others cite or feature them- Other
worldmedicalinnovation.org/speaker/anil-chandraker-md
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →worldmedicalinnovation.org ↗ - Other
myast.org/anil-chandraker-md-fasn-frcp-fast
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →myast.org ↗ - YouTube
youtube.com/watch
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
Editorial & leadership roles
journal and society appointments- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →umassmed.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →myast.org ↗
- Secretary
American Society of Transplantation
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ast.digitellinc.com ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →umassmed.edu ↗
Secondary affiliations
appointments beyond the home institution- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →umassmed.edu ↗
- Hospital affiliation
Brigham and Women's Hospital
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doctors.massgeneralbrigham.org ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →indianewengland.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.